✦ LIBER ✦

Phase I dose-escalating trial of KOS-862 (epothilone D) in patients with advanced malignancies

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

547 KOS-862 (Epothilone D): Phase 1 dose

✍ D.R. Spriggs; J. Dupont; S. Pezzulli; J. Larkin; G. Cropp; Y. Zhou; M. Sherrill; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Phase I dose escalation study of KOS-158

✍ Elaine T. Lam; Sanjay Goel; Larry J. Schaaf; Gillian F. Cropp; Alison L. Hannah; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 280 KB

Phase I clinical, pharmacokinetic, and p

✍ Jason Konner, Rachel N. Grisham, Jae Park, Owen A. O’Connor, Gillian Cropp, Robe 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 270 KB

A phase 1 study of KOS-862 (Epothilone D

✍ J. Paul Monk, Miguel Villalona-Calero, Joe Larkin, Greg Otterson, David S. Sprig 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 220 KB

Erratum to: Phase I clinical, pharmacoki

✍ Jason Konner, Rachel N. Grisham, Jae Park, Owen A. O’Connor, Gillian Cropp, Robe 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 56 KB

Phase I Dose Escalation Trial of Vandeta

✍ Emma C. Fields; Denise Damek; Laurie E. Gaspar; Arthur K. Liu; Brian D. Kavanagh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 387 KB